ClinicalTrials.gov
public full text
Public Domain
Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects
The Researchers are trying to learn more about how individuals break down and process medications based on their genes. The Researchers want to find out whether subjects will have fewer side effects if they take different medications based on their pharmacogenomics profile.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder#1308832
- YouScript IMPACT Registry#811226
- WHO Drug Information 2025, vol. 39, 1 [full issue]#166326
- WHO Drug Information 2025, vol. 39, 4 [full issue]#133936
- Factors contributing to medication safety incidents observed by community pharmacists - a content analysis of incident reports.#1204659
Record · ID 1431961
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive